The model for end-stage liver disease score-based system predicts short term mortality better than the current child-turcotte-pugh score-based allocation system during waiting for deceased liver transplantation

Journal of Korean Medical Science

Volumn 28, Issue 8, 2013, Pages 1207-1212

  Hong, Geun ^a   Lee, Kwang Woong ^a   Suh, Sukwon ^a   Yoo, Tae ^a   Kim, Hyeyoung ^a   Park, Min Su ^a   Choi, Youngrok ^a   Yi, Nam Joon ^a   Suh, Kyung Suk ^a  

^a Seoul National University   (South Korea)

Author keywords

Liver diseases; Liver transplantation; Meld score; Mortality; Survival; Waiting lists

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; COHORT ANALYSIS; END STAGE LIVER DISEASE; HOSPITAL ADMISSION; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; MELD SCORE; MORTALITY; RECEIVER OPERATING CHARACTERISTIC; REGISTER; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; SURVIVAL; SURVIVAL RATE; TIME;

LIVER DISEASES; LIVER TRANSPLANTATION; MELD SCORE; MORTALITY; SURVIVAL; WAITING LISTS;

AREA UNDER CURVE; COHORT STUDIES; END STAGE LIVER DISEASE; HUMANS; LIVER TRANSPLANTATION; MODELS, STATISTICAL; REGISTRIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; WAITING LISTS;

EID: 84884377836     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2013.28.8.1207     Document Type: Article

References (20)

1. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, Krom RA, Kim WR. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001; 7: 567-80.
2. Malinchoc M, Kamath PS, Gordon FD, Peine CJ Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-71.
3. Wiesner RH. Evidence-based evolution of the MELD/PELD liver allocation policy. Liver Transpl 2005; 11: 261-3.
4. Biselli M, Gitto S, Gramenzi A Di Donato R, Brodosi L, Ravaioli M, Grazi GL, Pinna AD, Andreone P, Bernardi M. Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? Liver Transpl 2010; 16: 964-73.
5. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-26.
6. Leise MD, Kim WR, Kremers WK, Larson JJ, Benson JT, Therneau TM. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. Gastroenterology 11; 140: 1952-60.
7. Lim YS, Larson TS, Benson JT, Kamath PS, Kremers WK, Therneau TM, Kim WR. Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol 2010; 52: 523-8.
8. Hwang S, Lee SG, Jung DH, Kim KH, Ha TY, Song GW. Simulation of deceased-donor liver graft allocation as UNOS status I or IIa on the current Korean setting for patients with hepatitis B virus-induced fulminant hepatic failure. Korean J Hepatobiliary Pancreat Surg 2009; 13: 31-6.
9. Lee JS. Changes of MELD: can exceed Child-Pugh's authority? Korean J Hepatol 2006; 12: 475-8.
10. Lim YS. Prediction of post-operative mortality in patients with cirrhosis: growth of child to MELD. Korean J Gastroenterol 2011; 57: 333-4.
11. Song CS, Yoon MY, Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI. Usefulness of model for end-stage liver disease score for predicting mortality after intra-abdominal surgery in patients with liver cirrhosis in a single hospital. Korean J Gastroenterol 2011; 57: 340-5.
12. Kim SY, Yim HJ, Lee J, Lee BJ, Kim DI, Jung SW, Han WS, Lee JS, Koo JS, Seo YS, et al. Comparison of CTP, MELD, and MELD-Na scores for predicting short term mortality in patients with liver cirrhosis. Korean J Gastroenterol 2007; 50: 92-100.
13. OPTN: Organ Procurement and Transplantation Network Available at http://optn.transplant.hrsa.gov/organDatasource/OrganSpecificPolicies. asp?display=Liver [accessed on January 2013].
14. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-6.
15. Kamath PS, Kim WR; Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology 2007; 45: 797-805.
16. Freeman RB Jr. Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card. Hepatology 2008; 47: 1052-7.
17. Stewart CA, Malinchoc M, Kim WR, Kamath PS. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 2007; 13: 1366-71.
18. Pomfret EA, Washburn K, Wald C, Nalesnik MA, Douglas D, Russo M, Roberts J, Reich DJ, Schwartz ME, Mieles L, et al. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl 2010; 16: 262-78.
19. Washburn K, Edwards E, Harper A, Freeman R. Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transplant 2010; 10: 1643-8.
20. Yao FY, Bass NM, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Liver Transpl 04; 10: 621-30.